3D ULTRASOUND MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On September 23, 2024, PIUR IMAGING received the U.S. FDA clearance for its PIUR tUS Infinity system, a groundbreaking 3D ultrasound technology that upgrades 2D ultrasound devices into advanced 3D imaging systems. Primarily aimed at thyroid imaging, this system provides detailed volumetric datasets, enhancing clinical decision-making and reducing operator dependency. The FDA approval marks the product's introduction to the U.S. healthcare sector, empowering clinicians with innovative, cost-effective imaging technology.
• On June 03, 2024, Fraunhofer, a Germany-based publicly-owned research organization, announced that its researchers had developed a 3D ultrasound technology for precise, non-invasive brain stimulation. This system targets specific brain areas to treat conditions like epilepsy, Parkinson's disease, and stroke aftereffects, offering a safer alternative to traditional methods like Deep Brain Stimulation (DBS).
• In May 2024, Royal Philips introduced the VeriSight Pro 3D ICE catheter globally, enabling hospitals in Hong Kong to improve procedural precision and patient outcomes through advanced imaging technology
• In February 2024, GE HealthCare unveiled its upgraded LOGIQ ultrasound portfolio at the European Congress of Radiology, featuring new AI-driven tools aimed at enhancing imaging capabilities in response to the growing shortage of radiologists
• In October 2022, researchers at the Beckman Institute received a US$ 2 Million NIH grant to develop FASTER, a device that instantly adds 3D capabilities to 2D ultrasound systems. This affordable, clip-on device aims to make high-quality, real-time 3D ultrasound imaging accessible in diverse, underserved communities. The system can integrate with existing 2D ultrasound probes, enhancing diagnostic capabilities, particularly for conditions like breast cancer.